Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of DR-3355 (levofloxacin) injection in surgical infection
jRCT2080221802Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levofloxacin in surgical site infection (SSI), biliary tract infection, acute cholecystitis and 1 more, sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
levofloxacin
03
Conditions
surgical site infection (SSI)biliary tract infectionacute cholecystitisacute cholangitis
Beyond the preview
Go deeper on jRCT2080221802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221802.